Dopamine D2 receptor genotype (C957T) and habitual consumption of sugars in a free-living population of men and women

Journal of Nutrigenetics and Nutrigenomics

Volumn 2, Issue 4-5, 2010, Pages 235-242

  Eny, Karen M ^a   Corey, Paul N ^a   El Sohemy, Ahmed ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

DRD2; Food intake behavior; Genotype; Heterosis; Mode of inheritance; Sex specific heterosis; Sugar

Indexed keywords

DOPAMINE 2 RECEPTOR; FRUCTOSE; GLUCOSE; LACTOSE; MALTOSE; SUCROSE;

ADULT; ANALYSIS OF COVARIANCE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FAT INTAKE; FEEDING BEHAVIOR; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROSIS; HOMOZYGOTE; HUMAN; MALE; POST HOC ANALYSIS; PRIORITY JOURNAL; PROTEIN INTAKE; SEX DIFFERENCE; SUGAR INTAKE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; ENERGY INTAKE; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXERCISE; FEMALE; FOOD HABITS; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUESTIONNAIRES; RECEPTORS, DOPAMINE D2; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 77950048413     PISSN: 16616499     EISSN: 16616758     Source Type: Journal    
DOI: 10.1159/000276991     Document Type: Article

References (46)

1. Stice E, Spoor S, Ng J, Zald DH: Relation of obesity to consummatory and anticipatory food reward. Physiol Behav 2009; 97: 551-560.
2. Volkow ND, O'Brien CP: Issues for DSM-V: should obesity be included as a brain disorder? Am J Psychiatry 2007; 164: 708-710.
3. Frank GK, Oberndorfer TA, Simmons AN, Paulus MP, Fudge JL, Yang TT, Kaye WH: Sucrose activates human taste pathways differently from artificial sweetener. Neuroimage 2008; 39: 1559-1569.
4. Haltia LT, Rinne JO, Merisaari H, Maguire RP, Savontaus E, Helin S, Nagren K, Kaasinen V: Effects of intravenous glucose on dopaminergic function in the human brain in vivo. Synapse 2007; 61: 748-756.
5. De Araujo IE, Oliveira-Maia AJ, Sotnikova TD, Gainetdinov RR, Caron MG, Nicolelis MA, Simon SA: Food reward in the absence of taste receptor signaling. Neuron 2008; 57: 930-941.
6. Duarte C, Biala G, Le Bihan C, Hamon M, Thiebot MH: Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats. Psychopharmacology (Berl) 2003; 166: 19-32.
7. Risinger FO, Freeman PA, Rubinstein M, Low MJ, Grandy DK: Lack of operant ethanol self-administration in dopamine D2 receptor knockout mice. Psychopharmacology (Berl) 2000; 152: 343-350.
8. Hajnal A, Norgren R: Accumbens dopamine mechanisms in sucrose intake. Brain Res 2001; 904: 76-84.
9. Zigmond MJ, Heffner TG, Stricker EM: The effect of altered dopaminergic activity on food intake in the rat: evidence for an optimal level of dopaminergic activity for behavior. Prog Neuropsychopharmacol 1980; 4: 351-362.
10. Calabrese EJ: Dopamine: biphasic dose responses. Crit Rev Toxicol 2001; 31: 563-583.
11. Del Parigi A, Chen K, Salbe AD, Reiman EM, Tataranni PA: Are we addicted to food? Obes Res 2003; 11: 493-495.
12. Haltia LT, Rinne JO, Helin S, Parkkola R, Nagren K, Kaasinen V: Effects of intravenous placebo with glucose expectation on human basal ganglia dopaminergic function. Synapse 2008; 62: 682-688.
13. Wang GJ, Volkow ND, Telang F, Jayne M, Ma Y, Pradhan K, Zhu W, Wong CT, Thanos PK, Geliebter A, Biegon A, Fowler JS: Evidence of gender differences in the ability to inhibit brain activation elicited by food stimulation. Proc Natl Acad Sci USA 2009; 106: 1249-1254.
14. Epstein LH, Temple JL, Neaderhiser BJ, Salis RJ, Erbe RW, Leddy JJ: Food reinforcement, the dopamine D2 receptor genotype, and energy intake in obese and non-obese humans. Behav Neurosci 2007; 121: 877-886.
15. Epstein LH, Wright SM, Paluch RA, Leddy JJ, Hawk LW Jr, Jaroni JL, Saad FG, Crystal- Mansour S, Shields PG, Lerman C: Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers. Am J Clin Nutr 2004; 80: 82-88.
16. Lerman C, Berrettini W, Pinto A, Patterson F, Crystal-Mansour S, Wileyto EP, Restine SL, Leonard DG, Shields PG, Epstein LH: Changes in food reward following smoking cessation: a pharmacogenetic investigation. Psychopharmacology (Berl) 2004; 174: 571-577.
17. Barnard ND, Noble EP, Ritchie T, Cohen J, Jenkins DJ, Turner-McGrievy G, Gloede L, Green AA, Ferdowsian H: D2 dopamine receptor Taq1A polymorphism, body weight, and dietary intake in type 2 diabetes. Nutrition 2009; 25: 58-65.
18. Stice E, Spoor S, Bohon C, Small DM: Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 2008; 322: 449-452.
19. Neville MJ, Johnstone EC, Walton RT: Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 2004; 23: 540-545.
20. Duan J, Wainwright MS, Comeron JM, Saitou N, Sanders AR, Gelernter J, Gejman PV: Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 2003; 12: 205-216.
21. Hirvonen MM, Lumme V, Hirvonen J, Pesonen U, Nagren K, Vahlberg T, Scheinin H, Hietala J: C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 630-636.
22. Davis C, Levitan RD, Kaplan AS, Carter J, Reid C, Curtis C, Patte K, Hwang R, Kennedy JL: Reward sensitivity and the D2 dopamine receptor gene: a case-control study of binge eating disorder. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 620-628.
23. Zhang Y, Bertolino A, Fazio L, Blasi G, Rampino A, Romano R, Lee ML, Xiao T, Papp A, Wang D, Sadee W: Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci USA 2007; 104: 20552-20557.
24. Lee HS: Gender-specific molecular heterosis and association studies: dopamine D2 receptor gene and smoking. Am J Med Genet B Neuropsychiatr Genet 2003; 118B:55-59.
25. Minelli C, Thompson JR, Abrams KR, Thakkinstian A, Attia J: The choice of a genetic model in the meta-analysis of molecular association studies. Int J Epidemiol 2005; 34: 1319-1328.
26. Elman I, Borsook D, Lukas SE: Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with secondgeneration antipsychotic agents. Neuropsychopharmacology 2006; 31: 2091-2120.
27. Spring B, Pagoto S, McChargue D, Hedeker D, Werth J: Altered reward value of carbohydrate snacks for female smokers withdrawn from nicotine. Pharmacol Biochem Behav 2003; 76: 351-360.
28. Eny KM, Wolever TM, Fontaine-Bisson B, El-Sohemy A: Genetic variant in the glucose transporter type 2 is associated with higher intakes of sugars in two distinct populations. Physiol Genomics 2008; 33: 355-360.
29. Holmes MD, Powell IJ, Campos H, Stampfer MJ, Giovannucci EL, Willett WC: Validation of a food frequency questionnaire measurement of selected nutrients using biological markers in African-American men. Eur J Clin Nutr 2007;61:1328-1336.
30. Ainsworth BE, Haskell WL, Leon AS, Jacobs DR Jr, Montoye HJ, Sallis JF, Paffenbarger RS Jr: Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993; 25: 71-80.
31. Young EA, Becker JB: Perspective: sex matters: gonadal steroids and the brain. Neuropsychopharmacology 2009; 34: 537-538.
32. Davis C, Fox J: Sensitivity to reward and body mass index: evidence for a non-linear relationship. Appetite 2008; 50: 43-49.
33. Comings DE, MacMurray JP: Molecular heterosis: a review. Mol Genet Metab 2000; 71: 19-31.
34. Lehmann DJ, Cortina-Borja M, Warden DR, Smith AD, Sleegers K, Prince JA, van Duijn CM, Kehoe PG: Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease. Am J Epidemiol 2005; 162: 305-317.
35. Jonsson E, Sedvall G, Brene S, Gustavsson JP, Geijer T, Terenius L, Crocq MA, Lannfelt L, Tylec A, Sokoloff P, Schwartz JC, Wiesel FA: Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biol Psychiatry 1996; 40: 1032-1043.
36. Hirvonen M, Laakso A, Nagren K, Rinne JO, Pohjalainen T, Hietala J: C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Mol Psychiatry 2004; 9: 1060-1061.
37. Hirvonen MM, Laakso A, Nagren K, Rinne JO, Pohjalainen T, Hietala J: C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity. Synapse 2009; 63: 907-912.
38. Thompson TL, Certain ME: Estrogen-mediated inhibition of dopamine transport in the striatum: regulation by G i/o. Eur J Pharmacol 2005; 511: 121-126.
39. Dick DM, Wang JC, Plunkett J, Aliev F, Hinrichs A, Bertelsen S, Budde JP, Goldstein EL, Kaplan D, Edenberg HJ, Nurnberger J Jr, Hesselbrock V, Schuckit M, Kuperman S, Tischfield J, Porjesz B, Begleiter H, Bierut LJ, Goate A: Family-based association analyses of alcohol dependence phenotypes across DRD2 and neighboring gene ANKK1. Alcohol Clin Exp Res 2007; 31: 1645-1653.
40. Huang W, Payne TJ, Ma JZ, Beuten J, Dupont RT, Inohara N, Li MD: Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample. Neuropsychopharmacology 2009; 34: 319-330.
41. Murphy G, Cross AJ, Sansbury LS, Bergen A, Laiyemo AO, Albert PS, Wang Z, Yu B, Lehman T, Kalidindi A, Modali R, Schatzkin A, Lanza E: Dopamine D2 receptor polymorphisms and adenoma recurrence in the Polyp Prevention Trial. Int J Cancer 2009; 124: 2148-2151.
42. Liang NC, Hajnal A, Norgren R: Sham feeding corn oil increases accumbens dopamine in the rat. Am J Physiol Regul Integr Comp Physiol 2006; 291:R1236-R1239.
43. Rao RE, Wojnicki FH, Coupland J, Ghosh S, Corwin RL: Baclofen, raclopride, and naltrexone differentially reduce solid fat emulsion intake under limited access conditions. Pharmacol Biochem Behav 2008; 89: 581-590.
44. Will MJ, Pratt WE, Kelley AE: Pharmacological characterization of high-fat feeding induced by opioid stimulation of the ventral striatum. Physiol Behav 2006; 89: 226-234.
45. Hajnal A NJ, Acharya NK, Kessler DA: Sucrose is more potent to prevent habituation of accumbens dopamine release than corn oil (abstract). Appetite 2009; 52: 835.
46. Shibata R, Kameishi M, Kondoh T, Torii K: Bilateral dopaminergic lesions in the ventral tegmental area of rats influence sucrose intake, but not umami and amino acid intake. Physiol Behav 2009; 96: 667-674.